Israel-based Sensible Medical Innovations, which has created a device that monitors chronic diseases such as congestive heart failure externally, has chosen Columbus as the site of its U.S. headquarters, reports Business First of Columbus.
Tom Sudow, director of business development for Cleveland's Global Cardiovascular Innovation Center, said the headquarters could potentially be located at the TechColumbus incubator.
Read the full story here.